Monoclonal antibody as a targeting mediator for nanoparticle targeted delivery system for lung cancer

Lung cancer is the second most common type of cancer after breast cancer. It ranks first in terms of mortality rate among all types of cancer. Lung cancer therapies are still being developed, one of which makes use of nanoparticle technology. However, conjugation with specific ligands capable of del...

Descripción completa

Detalles Bibliográficos
Autores principales: Wathoni, Nasrul, Puluhulawa, Lisa Efriani, Joni, I Made, Muchtaridi, Muchtaridi, Mohammed, Ahmed Fouad Abdelwahab, Elamin, Khaled M., Milanda, Tiana, Gozali, Dolih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467540/
https://www.ncbi.nlm.nih.gov/pubmed/36085575
http://dx.doi.org/10.1080/10717544.2022.2120566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467540/
https://www.ncbi.nlm.nih.gov/pubmed/36085575
http://dx.doi.org/10.1080/10717544.2022.2120566

Ejemplares similares